POIDOMANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 187
AS - Asia 118
EU - Europa 98
AF - Africa 25
SA - Sud America 20
Totale 448
Nazione #
US - Stati Uniti d'America 185
RU - Federazione Russa 50
SG - Singapore 48
CN - Cina 37
BR - Brasile 18
CI - Costa d'Avorio 17
IT - Italia 15
VN - Vietnam 11
IE - Irlanda 9
KR - Corea 8
IN - India 6
GB - Regno Unito 5
SN - Senegal 4
DE - Germania 3
FR - Francia 3
BE - Belgio 2
HK - Hong Kong 2
LT - Lituania 2
NG - Nigeria 2
TR - Turchia 2
UA - Ucraina 2
AT - Austria 1
BD - Bangladesh 1
BJ - Benin 1
BS - Bahamas 1
CA - Canada 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
ID - Indonesia 1
KE - Kenya 1
LK - Sri Lanka 1
MY - Malesia 1
NL - Olanda 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SE - Svezia 1
Totale 448
Città #
Singapore 35
Santa Clara 31
Moscow 21
Dallas 19
Abidjan 17
Houston 17
Hefei 16
San Jose 16
Ashburn 9
Chicago 9
Dublin 9
Beijing 8
Seoul 8
Chandler 7
Civitanova Marche 6
Los Angeles 6
Boardman 5
Catania 5
Dakar 4
Hanoi 4
Ho Chi Minh City 4
Lauterbourg 3
London 3
Brussels 2
Buffalo 2
Chennai 2
Council Bluffs 2
Hong Kong 2
Milan 2
Mumbai 2
New York 2
Orem 2
Phoenix 2
Abuja 1
Amsterdam 1
Andover 1
Ankara 1
Atlanta 1
Belgrade 1
Boa Vista 1
Boston 1
Brasília 1
Cambridge 1
Can Tho 1
Canoas 1
Chone 1
Cleveland 1
Colombo 1
Columbus 1
Concórdia 1
Cotonou 1
Curitiba 1
Darmstadt 1
Delhi 1
Denver 1
Donetsk 1
Florence 1
Fortaleza 1
Franca 1
Galesburg 1
Gravataí 1
Guarapuava 1
Guaratinguetá 1
Hopkins 1
Istanbul 1
Kingsville 1
Kuala Lumpur 1
Las Vegas 1
Lawrence 1
Lisbon 1
Marília 1
Montes Claros 1
Munich 1
Nassau 1
Offenbach 1
Olinda 1
Osasco 1
Ottawa 1
Poplar 1
Port Harcourt 1
Porto Velho 1
Presidente Dutra 1
Rajkot 1
San Francisco 1
San Martino di Lupari 1
Santiago 1
Stockholm 1
Surubim 1
Tappahannock 1
The Dalles 1
Valencia 1
Vila Velha 1
Warsaw 1
Washington 1
Wilmington 1
Totale 344
Nome #
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network 126
Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation 125
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 120
Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: Association with CD34+ mobilization and with disease-free survival 81
Totale 452
Categoria #
all - tutte 1.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/20225 0 1 0 0 1 0 1 0 1 0 0 1
2022/202335 3 0 1 2 6 4 2 10 2 0 3 2
2023/202434 3 9 1 1 3 7 0 3 0 1 5 1
2024/2025101 3 15 7 10 22 12 0 3 2 7 12 8
2025/2026257 19 24 34 26 37 56 21 6 17 17 0 0
Totale 452